Dirk Haussecker @RNAiAnalyst

Biotech enthusiast with a stock trading focus on nucleic acid-based and -targeted biotech. https://t.co/dfLqOuH7Uh Germany Joined November 2011

Tweets

39K
Followers

20K
Following

514
Likes

21K

Dirk Haussecker @RNAiAnalyst

10 hours ago

$cmps we have all witnessed how impactful the politicization of #FDA is. This can only be good for #psychedelics.

13 1 8 2K 0

#biotech gains about to beget further gains. When people notice their biotech-investing friends/family smiling again and living it up, more will invest. Not some abstract macro thing or medical breakthrough that gets #generalists involved.

12 4 34 5K 1

Dirk Haussecker @RNAiAnalyst

2 days ago

$qure knows that high-dose should be plenty. Now testing lower dose for risk/benefit. DSMB allowed high-dose to continue...so it's still possible that it will be the go-forward dose. $sgmo

11 0 8 4K 0

Download Image

Dirk Haussecker @RNAiAnalyst

2 days ago

$qure so now we have intriguing epilepsy and Fabry data ahead of Huntington's binary. To cushion the blow?

12 1 6 3K 1

Dirk Haussecker @RNAiAnalyst

2 days ago

$sgmo kiss goodbye to Fabry deal, unless there are >2 Big Pharmas desperately bidding for such products...which I doubt. $qure

4 1 6 3K 3

Dirk Haussecker @RNAiAnalyst

2 days ago

#CRISPR And let's remember that it is the sickest people that rely on employer-based health insurance. This should only speed up employment-aged ATTR and HAE patients switching from traditional drugs to one-time genome editing. $NTLA

Spencer Hakimian @SpencerHakimian

3 days ago

581 3K 15K 987K 3K

Download Image

2 1 9 4K 1

Dirk Haussecker @RNAiAnalyst

3 days ago

Will #biotech trade up if #RFK gets fired over next couple of days?

17 1 4 3K 0

Dirk Haussecker @RNAiAnalyst

3 days ago

$srrk feels like market is short-sighted by focusing on manufacturing risk ahead of PDUFA. Whether there'll be a slight delay or not due to manufacturing, their drug should sell very well in SMA.

12 0 10 3K 1

Dirk Haussecker @RNAiAnalyst

3 days ago

Labor market SCREAMING for rate cut. I believe Powell more concerned about workforce than inflation. Sep rate cut almost a certainty imo. #biotech

First Squawk @FirstSquawk

3 days ago

Labor market SCREAMING for rate cut. I believe Powell more concerned about workforce than inflation. Sep rate cut almost a certainty imo. #biotech

878 4K 21K 10.7M 2K

7 1 11 4K 0

Dirk Haussecker @RNAiAnalyst

3 days ago

$SNY be it atopic dermatitis, hidradenitis suppuritiva etc...p2 --> p3 results measuring improvement from baseline can differ greatly depending on patient pop (severe/moderate), geography (SOC) etc $NKTR $MTLX

4 0 3 2K 0

Dirk Haussecker @RNAiAnalyst

3 days ago

$ions does AZ agreement preclude them from pursuing a competing ATTR #CRISPR? $mgx $ntla

6 0 4 2K 1

Dirk Haussecker @RNAiAnalyst

4 days ago

$NKTR efficacy better:

Michel Doepke @doepke_michel

4 days ago

$NKTR efficacy better: https://t.co/pglsmLpIoP

2 0 23 14K 2

Download Image

4 2 26 10K 2

Download Image

Dirk Haussecker @RNAiAnalyst

4 days ago

#longevity No wonder #China recognizes potential as Xi says this century humans predicted to vive to 150, and even Ruusia's Putin: through on-demand organ-replacement keep living longer. #biotech is here to stay...bigger than AI if you value life.